13G/A filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC and 2 other reporting persons reported 314,409 IMUX shares, 2.3% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 22:58:13 UTC.
- Accession
- 0000947871-26-001032
- Filer
- CIK 1055951
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- IMUX · Immunic, Inc.
- Shares
- 314,409
- Percent of class
- 2.3%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group ORBIMED ADVISORS LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | IA | 0 | 314,409 | 0 | 314,409 | 314,409 | 2.3% |
| OrbiMed Genesis GP LLC | OO | 0 | 314,409 | 0 | 314,409 | 314,409 | 2.3% |
| OrbiMed Capital LLC | IA | 161,395 | 0 | 161,395 | 0 | 161,395 | 1.2% |